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C-reactive protein (CRP) and serum amyloid A (SAA) are acute-phase proteins mainly synthesized by the liver in response to some
cytokines. They are potentially useful to diagnosing infection and monitoring diﬀerent clinical conditions. The aim of this study
was to measure SAA and CRP in maternal and cord blood during and after delivery and try to correlate these proteins with tumor
necrosis factor-α, interleukin-1β, and interleukin-8. Acute-phase proteins and cytokines were measured by ELISA in 24 healthy
pregnantwomenundergoingvaginaldeliveryorCesareansection.Cordbloodsamplesinadditiontomaternalbloodwerecollected.
SAA and CRP reached the maximum maternal serum levels 24 hours after delivery, while cytokines remained constant over time.
SAA and CRP were signiﬁcantly higher in maternal serum than in newborn’s (P<. 001) at the moment of delivery. SAA and CRP,
regardless of the type of delivery, reproduce the common pattern observed in most inﬂammatory conditions. Proinﬂammatory
cytokine serum levels do not mirror the increase in SAA and CRP levels.
INTRODUCTION
C-reactive protein (CRP) is an acute-phase protein
whose levels in blood rise up to 1000-fold in response to
injuries, trauma, infection, inﬂammation, and neoplasia
[1, 2, 3, 4]. Because of the potential usefulness of CRP
to diagnosing infection in pregnant women, many stud-
ies have described alterations of CRP during pregnancy,
labor, and postpartum in normal conditions and disease.
Humans have another important acute-phase protein be-
sides CRP: serum amyloid A (SAA) [1, 2, 4, 5, 6, 7].
The determination of SAA has improved in recent years,
prompting studies that attempt to establish comparisons
with CRP [1, 7, 8, 9, 10], as well as its usefulness in moni-
toringdiﬀerentclinicalconditions[2,4,5,8,9,11,12,13].
CRP and SAA display a similar pattern in most in-
ﬂammatory diseases, reaching a maximum serum con-
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centration about 24 hours after the inﬂammatory process
sets in and then slowly decreasing. SAA has been consid-
ered better than CRP to monitor or diagnose viral infec-
tionsandnoninvasiveorearlyinvasivebacterialinfections
[7, 11, 12, 13]. An additional advantage of SAA seems to
be its sensitivity in the diagnosis of transplant rejection,
particularly in the case of renal grafts [14].
Here, we compare CRP with SAA in serial blood sam-
ples taken during vaginal and Cesarean delivery. Our in-
terest in establishing normal values for the concentra-
tion of these two acute-phase proteins in labor and post-
p a r t u ma l s ol e du st os e e kac o r r e l a t i o nb e t w e e na c u t e -
phase proteins and some inﬂammatory cytokines. The
reason for this investigation was based on our previ-
ous studies, which showed that SAA is a potent stimu-
lus for the release of proinﬂammatory cytokines in leuko-
cyte cultures [15, 16, 17]. Although some studies deter-
mined the concentration of cytokines in maternal and
cord blood and their correlation with cervical dilata-
tion [18], neonatal disease [19], gestational age newborn
[20] and perinatal period [21], none of these studies
tried to correlate cytokines with the acute-phase protein
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Table 1. Concentration of acute-phase proteins and cytokines in maternal serum upon admission for delivery, at the moment of
delivery, and after delivery (24 and 60 hours) in vaginal delivery (VD), where n = 12 and Cesarean section (CD), where n = 12.
Values are mean and standard deviation. nd denotes nondetectable. ∗ denotes that P<. 01 compared to admission and moment of
delivery and † denotes that P = .01: CD diﬀered from VD (variance analysis).
Acute-phase proteins and cytokines Delivery type Admission Delivery 24h 60h
SAA (µg/mL) VD 7.1 ±4.41 2 ±11 230 ±32∗ 224 ±43∗
CD 39 ±108 12 ±12 288 ±106∗ 325 ±110∗
CRP (mg/dL) VD 0.6 ±0.40 .9 ±0.75 .8 ±3.6∗ 2.8 ±1.5∗
CD 1.8 ±2.41 .2 ±0.91 1 ±5.3∗,† 9.4 ±4.8∗,†
TNF-α (pg/mL) VD 3.9 ±3.44 .9 ±3.36 .0 ±3.74 .4 ±3.0
CD 3.5 ±1.63 .8 ±1.83 .8 ±1.83 .1 ±1.7
IL-1β (pg/mL) VD nd nd nd nd
CD nd nd nd nd
IL-8 (pg/mL) VD 8.0 ±15 11 ±15 32 ±31 24 ±59
CD 5.2 ±3.46 .8 ±6.26 .1 ±3.76 .6 ±5.2
MATERIAL AND METHODS
This study was approved by and followed the guide-
lines of the Ethical Committee of the Hospital Univer-
sit´ ario and Faculdade de Ciˆ encias Farmacˆ euticas at the
Universidade de S˜ ao Paulo, Brazil. All the subjects were
informed of the aims and procedures of the investigation
and gave their written consent.
Pregnanthumansubjects
Healthy pregnant women volunteers were recruited
for this study upon their admission for delivery at term.
Entry criteria for all the subjects included no known
health problems, and no autoimmune, infectious, or in-
ﬂammatory diseases. The subjects had been in delivery at
term (around 39 weeks), with rupture of membranes less
than 6 hours prior to delivery. The ﬁrst group comprised
12 women (aged 21 ± 4 years) in term labor who under-
went a vaginal delivery. The second group consisted of 12
women (aged 26 ± 7 years) in term labor, who developed
some form of complication during labor (dystocia or fetal
distress) and had undergo Cesarean section delivery.
Collectionofblood
Serum samples were collected from each volunteer at
themomentofadmissionwithsignsoflabor,immediately
postpartum (with a concomitant cord blood specimen),
24 and 60 hours after delivery. The serum samples were
stored at −70◦C until the determinations were made.
EnzymeimmunoassayforCRP,TNF-α,
IL-1β,andIL-8
Samples of serum were thawed and assayed in batches
in a semiautomated analyzer (Immulite System, Diagnos-
tic Products Corporation, Los Angeles, Calif) for chemi-
luminescent enzyme immunoassays (ELISA) using com-
mercial kits. The analytical sensitivity and accuracy for
CRP, TNF-α,I L - 1 β, and IL-8 were 0.01mg/dL, CV 7.3%;
1.7pg/mL,CV3.2%;1.5pg/mL,CV4.2%;and2.0pg/mL,
CV 3.7%, respectively.
EnzymeimmunoassayforSAA
Samples of serum were diluted 1:20, 1:500 or 1:5000,
and then tested through ELISA on 96-well microtiter
plates (Phase Range Serum Amyloid A Assay, Tridelta De-
velopment Limited, Maynooth, Kildare, Ireland).
Statisticalanalysis
Since the data obtained were not symmetrically dis-
tributed, log-transformed results were used for statistical
analysis in order to obtain approximately normal distri-
bution. All analysis was performed using statistical soft-
ware (SPSS version 8.0) and was evaluated by analysis of
variance, t test, and correlations.
RESULTS
The serum concentrations of SAA, CRP, TNF-α,I L -
1β, and IL-8 in maternal blood at the moment of admis-
sion, during and after delivery were determined in two
diﬀerent groups: vaginal delivery (VD) and Cesarean de-
livery (CD) (Table 1). A parallel increase of SAA and CRP
concentrations was observed at 24 and 60 hours postpar-
tum, with maximum values at 24 hours (P<. 01). A dif-
ference was found between VD and CD (P = .01) only for
CRP; this diﬀerence was observed after 24 and 60 hours.
The maternal serum concentration of TNF-α,I L - 1 β,a n d
IL-8 remained constant during all the periods of collec-
tion, regardless of the type of delivery.
All the parameters measured in maternal blood at de-
livery were also determined in cord blood. Given that no
diﬀerences were found in cord blood samples obtained in
bothVDandCD,thedataweregroupedandfurthercom-
pared with maternal serum (Figure 1). No correlation be-
tween maternal and cord blood values was found for any
parameter.However,signiﬁcantdiﬀerenceswereobserved
in SAA, CRP, and TNF-α between maternal and cord
blood. The concentrations of SAA and CRP were much
higher in maternal blood than in cord blood (P<. 001).
The concentration of TNF-α in cord blood was slightly
higher than in maternal blood (P<. 05).98 Luciane Marzzullo Cicarelli et al 2005:2 (2005)
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Figure 1. Concentration of SAA, CRP, TNF-α, and IL-8 in maternal and umbilical cord blood at delivery. The lines link values found
in individual cases. (∗ denotes that P<. 05 and ∗∗ denotes that P<. 001 for comparisons between the mother and cord blood
groups).
DISCUSSION
The concomitant increase in SAA and CRP repro-
duces the common pattern observed in most inﬂam-
matory conditions [13]. The CRP values after deliv-
ery increased 10- to 20-fold when compared with those
recorded upon admission, which were similar to the clin-
ical reference value (lower than 0.5mg/dL). The increase
in SAA during delivery was higher than CRP, which was
20- to 30-fold higher than upon admission (Table 1). The
acute-phaseresponseduringdeliverypossiblyprotectsthe
mother from the injury and mechanical eﬀects of labor
and these increased levels may be associated with host de-
fense mechanisms. CRP increases bacterial phagocytosis
andpromotestheclearanceofdeathcells[22].SAAcauses
the priming of neutrophils, which contributes to bacte-
rial death [23], and activates the synthesis of proinﬂam-
matory cytokines [15, 16, 17]. Moreover, SAA seems to
induce adhesion, migration, tissue inﬁltration, and secre-
tionofneutrophilenzymes[5].Alltheseactivitiesindicate
animportantroleinhostdefense,preventionofinfection,
and repair.
The increase in acute-phase proteins observed in in-
ﬂammatory conditions usually relates to the intensity of
injuries. In delivery, the intensity of stress in CD may be
higher than in VD. Our ﬁndings indicated that CRP dis-
criminates between the two conditions, while SAA does
not. Be that as it may, our data highlighted the diﬃculty
ofusingCRPandSAAasmarkersofmaternalinfectionin
the postpartum period.
In earlier reports, we showed that SAA is a potent
stimulus for the release of proinﬂammatory cytokines by
leukocytes [15, 16, 17]. However, although SAA is high
in maternal serum in the postpartum period, it does2005:2 (2005) SAA, CRP, and Cytokines During and After Delivery 99
not correlate with serum concentration of cytokines. Cy-
tokinesareimportantinmanystagesofpregnancyandla-
bor[24,25,26,27],arelocallyproducedingestationaltis-
sues, and are present in cervico-vaginal and amniotic ﬂu-
ids. Nevertheless, these events are not reﬂected in the ma-
ternal serum, as revealed by the unaﬀected levels of TNF-
α, IL-8, and IL-1β during delivery (Table 1). Therefore,
the production and eﬀect of cytokines seem to be strictly
localized and the same may be at least partially true for
SAA.
Even though SAA is active in leukocytes, when the
SAA is bound to high-density lipoprotein (the form
present in serum), it does not trigger a stimulatory ef-
fect on leukocytes [15]. A localized eﬀect of SAA has been
foreseen in tissues that express this protein, for example,
placenta [28].
Although the concentration of SAA and CRP in the
mother’s serum at the moment of delivery is, in some
cases, slightly higher than the basal level, in all the cases
studied it was much higher than the levels found in cord
blood. This ﬁnding reinforces the idea that there is a lack
of transplacental transfer of these proteins during labor
[1]. Thus, any increase in the newborn CRP and SAA lev-
els may be a sign of infection or trauma. With regard to
cytokines, it was observed that concentrations of TNF-α
were higher in cord than in maternal blood in every case.
The concentration of TNF-α in cord blood may originate
exclusively from fetal and placental tissues and may con-
tribute to neonatal host defense [29].
In conclusion, our ﬁndings show that the kinetics of
the acute-phase proteins SAA and CRP, independently of
thetypeofdelivery,weresimilarandcannotbecorrelated
with maternal levels of cytokines. SAA and CRP could not
be used to diagnose maternal infection in the postpartum
period, butmaybe usefulto diagnosing neonatal diseases.
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